NJF Capital serves as a bridge between traditional business and industry-defining technologies. We use our experience to support transformative entrepreneurs who want to define and disrupt new and existing industries.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann.
NJF Capital invests internationally in companies developing transformative technologies across life sciences, deep tech, fintech, and the future of human performance.
As part of NJF Holdings – which also includes NJF Private Equity, and NJF Real Estate – NJF Capital focuses on ventures with the potential to scale globally and deliver lasting impact.
Investing in breakthrough biology, precision medicine, computational drug discovery, and health platforms that extend longevity and improve population-level outcomes.
Backing frontier AI, autonomous technologies, secure compute, quantum research, and data infrastructure that underpins the next era of innovation.
Supporting emerging technologies at the edge of science – from novel materials to bio-data convergence – with the potential to reshape industries and strengthen societal resilience.
Our role is simple – to help build technologies and systems that last longer than the headlines about them.